Anthelmintic efficacy of abamectin with fluazuron association in control of the gastrointestinal nematodes of cattle
ABSTRACT. Coelho C.N., Oliveira G.F., Coumendouros K., Moraes P.A., Medeiros M.T., Borges D.A., Nascimento C.G. do, Correia T.R. & Scott F.B. [Anthelmintic efficacy of abamectin with fluazuron association in control of the gastrointestinal nematodes of cattle.] Eficácia anti-helmíntica da associação de abamectina com fluazuron no controle dos principais nematoides gastrintestinais de bovinos. Revista Brasileira de Medicina Veterinária, 37(Supl.1):100-105, 2015. Curso de Pós-Graduação em Ciências Veterinárias, Instituto de Veterinária, Anexo 1, Universidade Federal Rural do Rio de Janeiro, Campus Seropédica, Ecologia, BR 465 Km 7, Seropédica, RJ 23897-970, Brasil. E-mail: email@example.com The aim of the study was to evaluate the anthelmintic efficacy of 0.6% abamectin associated with 3.0% fluazuron used respectively at doses of 600mcg and 3mg/kg of body weight by “pour-on” route in cattle, for the control of gastrintestinais nematodes Haemonchus placei, Cooperia punctata, Cooperia pectinata, Oesophagostomum radiatum and Trichostrongylus axei. To this end, two studies were conducted, a controlled one with euthanasia and necropsy, the other one evaluating the decrease of eggs per gram of feces (EPG) at the field level. For anthelmintic efficacy of the controlled study, the test product showed anthelmintic efficacy results of 92.59% for H. placei; 97.62% for T. axei; 87.82% for C. punctata; 86.96% for C. pectinata and 96% for O. radiatum. In the test conducted at a field level (EPG), the product has experienced an 92.17% efficacy results for the day +7; 89.32% for the day +14; 87.38% for day +21. The combination of abamectin and fluazuron was effective in the control of artificial infection by H. placei, O. radiatum, T. axei; and moderately effective in controlling artificial infections C. pectinata and C. punctata. The product test also showed a reduction of eggs per gram of feces (EPG) in cattle naturally infected.
Authors retain the copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Creative Commons Attribution License (CC BY-NC 4.0), allowing the sharing of work with acknowledgement of the authorship of the work and initial publication in this journal. They may take additional contracts separately, with acknowledgement of authorship and initial publication in this journal. They are authorized to publish and distribute their work online after publication by BJVM.
The AUTHOR is informed and agrees with the journal that, therefore, its article may be incorporated into existing databases and scientific information systems (indexers and current databases) or existing in the future (indexers and future databases), under the conditions defined by the latter at all times, which shall at least involve the possibility that the holders of these databases may perform the following actions on the article: Reproduce, transmit and distribute the article, in whole or in part in any form or means of electronic transmission existing or developed in the future, including electronic transmission for research, viewing and printing purposes; extract figures, tables, illustrations, and other graphic objects, and capture metadata, captions, and related articles for search, preview, and print purposes. Scan and/or store images and electronic article text.